drug Experts
Connect for media, speaking, professional opportunities & more.
Filters
Professor Richard Martin
Reader, Electrical, Electronic & Power Eng, Aston Institute of Materials Research (AIMR)Aston University
Dr Martin's research interests include bioactive glass and structural studies.
Jeffrey Cohn
Managing PartnerElevate Partners (A DHR Company)
Expert in leadership, assessment and corporate culture. Author, Wall Street Journal & Huffington Post Contributor.
Michael Hamblin, PhD
Principal Investigator, Wellman Center for Photomedicine at Massachusetts General HospitalAssociate Professor, Dermatology, Harvard Medical School
Dr. Hamblin's research interests are now broadly in the area of phototherapy for multiple diseases
Alexandra Noël
Associate Professor and Director of Inhalation LaboratoryLouisiana State University
Dr. Noël's research focuses on the production and characterization of aerosols, as well as inhalation and developmental toxicology.
David Bader
Distinguished Professor, Data ScienceNew Jersey Institute of Technology
Interests lie at the intersection of data science & high-performance computing, with applications in cybersecurity
Sherry Pagoto, Ph.D.
Professor of Allied Health SciencesUniversity of Connecticut
Leveraging technology for health promotion and disease prevention
Paola Marignani PhD, MBA
ProfessorDalhousie University, Faculty of Medicine
Dr. Paola Marignani is a scientist dedicated to developing personalized precision medicine that will improve human health.
Dr Jill Johnson
Senior Lecturer, School of BiosciencesAston University
Dr Johnson’s current research interests focus on the role of pericytes in chronic lung disease.
Deborah Kurrasch
Associate Professor, Department of Medical GeneticsUniversity of Calgary
Kurrasch’s research is focused on genetic programs that govern hypothalamic development using both mice and zebrafish as model organisms.
Gerry Brunk
Managing DirectorLumira Ventures
Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.